Basics & safetyPreclinical
PNC-27: a cancer peptide that has never been tested in patients
PNC-27 kills cancer cells in dishes and in some mouse experiments. No human trial exists, and online claims that it treats cancer have no clinical support.
PNC-27
An experimental p53-derived peptide that kills cancer cells in dishes and mice; it has never been tested in a human clinical trial.
- Also known as
- p53–penetratin chimeric peptide
- Area
- Basics & safety
- Status
- Experimental; not approved anywhere; FDA has warned patients not to use it